In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of CytomX Therapeutics Inc (NASDAQ: CTMX) closed at $2.50 in the last session, up 17.37% from day before closing price of $2.13. In other words, the price has increased by $17.37 from its previous closing price. On the day, 24.16 million shares were traded.
Ratios:
We take a closer look at CTMX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.73 and its Current Ratio is at 1.73. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.11.
On May 28, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $2.25 to $3.50.
Wedbush Upgraded its Neutral to Outperform on May 09, 2024, while the target price for the stock was maintained at $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 18 ’25 when McCarthy Sean A. sold 37,656 shares for $0.60 per share. The transaction valued at 22,556 led to the insider holds 995,195 shares of the business.
Ogden Christopher sold 8,551 shares of CTMX for $5,122 on Mar 18 ’25. The Chief Financial Officer now owns 201,026 shares after completing the transaction at $0.60 per share. On Mar 18 ’25, another insider, Chu Yu-Waye, who serves as the Chief Medical Officer of the company, sold 4,025 shares for $0.60 each. As a result, the insider received 2,411 and left with 135,725 shares of the company.
Valuation Measures:
As of this moment, CytomX’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.37 while its Price-to-Book (P/B) ratio in mrq is 8.05.
Stock Price History:
Over the past 52 weeks, CTMX has reached a high of $2.18, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is 240.65%, while the 200-Day Moving Average is calculated to be 155.30%.
Shares Statistics:
A total of 80.62M shares are outstanding, with a floating share count of 78.64M. Insiders hold about 2.46% of the company’s shares, while institutions hold 56.64% stake in the company.
